Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Technology Strategy - Short Courses in Small Company Management

Publication date: Sep 01, 2011 02:56 PM

Start: Mar 26, 2012 09:00 AM
End: Mar 30, 2012 05:00 PM

[image reference is broken]

The general objective of this 5-day course is to provide participants with a set of skills and instruments to manage firms in high-technology sectors and to understand industry dynamics in these sectors.

To this end the course introduces conceptual frameworks based on cutting-edge research in economics, strategy and technology management.

Find out more >>